IL2 and neoplasm: In addition, the relevance of combining NK cell infusion and inhibitory receptor blockade is reinforced by our preclinical mouse model data, which demonstrated the potent antitumor role of IL-2 NK infusion when inhibitory receptors are not engaged by tumor targets.